Navigation Links
Ontario Institute for Cancer Research Announces Investment in Microfluidics Technology for the Discovery of Anti-Cancer Drugs
Date:3/24/2011

ets containing mammalian cells to be addressed with compounds from chemical libraries in a highly efficient and low-cost manner, allowing automated, fast, and reliable analysis of chemical entities. Most importantly, a much smaller amount of cells and reagents are required to do the same testing.

The principal investigators for the Smart Well Plate™ are Dr. Aaron Wheeler, Associate Professor of Chemistry at the University of Toronto, and internationally recognized analytical chemist and renowned cancer expert Dr. Jeff Wrana, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto.

"Ontario is proud to be home to world-class researchers like Dr. Aaron Wheeler and Dr. Jeff Wrana," said Glen Murray, Ontario's Minister of Research and Innovation. "Along with supporting the pursuit of new and better cancer treatments, the province's investments in OICR are helping promote R&D commercialization, capitalizing on opportunities to develop new technologies and create jobs."

OICR's investment is administered through the Intellectual Property Development and Commercialization Program, which provides seed funding for late stage academic projects that meet specific market-oriented criteria.  

OICR will work closely with MaRS Innovation, the lead commercialization agent for this technology and the Innovations & Partnerships Office of the University of Toronto to support effective commercialization.

About OICR

OICR, based in Ontario, Canada, is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancer. The Institute is an independent, not-for-profit corporation funded by the Government of Ontario through the Ministry of Research and Innovation. OICR has 500 scientific staff (located at its headquarters and in research institutes and academia across the Province of Ontario) and an $85 million annual ope
'/>"/>

SOURCE The Ontario Institute for Cancer Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
2. Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
3. Koch Institute for Integrative Cancer Research Dedicated Today
4. Sharpest microscope tip lands Canadas Nanotech Institute in Guinness Book of World Records
5. Weizmann Institute scientists used accelerated evolution to develop enzymes that provide protection against nerve gas
6. Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer
7. Larta Institute NIH Success Stories Featured in 2011 California Biomedical Industry Report
8. Tufts Launches Institute for Biopharmaceutical Partnerships
9. Salk Institute Celebrates Grand Opening of the Waitt Advanced Biophotonics Center
10. Will Rogers Institute Awards Top Doctor $50,000 for Outstanding Contributions to Lung Research
11. Weizmann Institute scientists used accelerated evolution to develop enzymes that provide protection against nerve gas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 uBiome, the ... a partnership with PicnicHealth, a healthcare company that ... diagnosed with Inflammatory Bowel Disease (IBD) will receive ... complementary uBiome research kit. Both companies were funded ... , For more information on this partnership ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
(Date:5/20/2015)... Pa. , May 20, 2015  Select ... that the Federal Trade Commission granted early termination ... Antitrust Improvements Act of 1976, as amended, applicable ... MJ Acquisition Corporation, a joint venture that Select ... L.P. As previously announced, MJ Acquisition ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... DNDN ) today announced the following data ... annual meeting in Orlando, Florida. ... the Control Arm in Phase 3 Sipuleucel-T Studies," abstract ... (A33) from 4:50 to 6:20 p.m. ET on Thursday, ...
... Codexis, Inc. (Nasdaq: CDXS ) today announced that ... elected to the company,s Board of Directors. Senator Dorgan retired ... in the U.S. Congress.   (Photo:   http://photos.prnewswire.com/prnh/20110217/SF50619 ... Dorgan to our Board," said Alan Shaw, Ph.D., President and ...
... AMDeC, LLC announced today the expansion of ... by BioStorage Technologies, Inc., a global leader in ... logistics.  This partnership will create substantial savings for ... and relocation services offered by BioStorage Technologies. AMDeC ...
Cached Biology Technology:Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting 2Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting 3Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting 4Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting 5Former Senator Byron Dorgan Elected to Codexis Board 2AMDeC's Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services 2AMDeC's Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services 3AMDeC's Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services 4
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
(Date:4/27/2015)... FORT LAUDERDALE, Fla. , Apr. 27, 2015 /PRNewswire/ ... provider of access control and security systems is pleased ... joined the company as a consultant and member of ... Bedore is widely known as a thought leader ... Socrates Distance Learning Technology Group, and has published studies ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... UK e-Science project are helping to solve two ... avoid arsenic contamination of drinking water extracted from ... of removing the now-banned industrial chemical, dioxin, from ... and grid computing to simulate all the possible ...
... Clemson University chemists have developed a method to ... someday help researchers track the motion of a single ... The chemists are exploiting a process called resonance energy ... to the nanoparticles. Their findings will be reported at ...
... why you should listen to your mother when she ... present at high levels in a precursor form in ... prevent the severe blistering and skin breakage brought on ... bullosa simplex (EBS). The researchers treated newborn mice ...
Cached Biology News:e-Science points to pollution solutions 2Clemson scientists shed light on molecules in living cells 2Natural chemical found in broccoli helps combat skin blistering disease 2
...
Protein Marker Detection Pack contains biotinylate...
...
AM100 is an aqueous-based, permanent mounting media designed for use with alkaline phosphatase and immunoperoxidase stained tissue sections....
Biology Products: